1. Home
  2. PRTS vs CTSO Comparison

PRTS vs CTSO Comparison

Compare PRTS & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarParts.com Inc.

PRTS

CarParts.com Inc.

N/A

Current Price

$0.82

Market Cap

44.4M

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$0.80

Market Cap

45.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRTS
CTSO
Founded
1995
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.4M
45.7M
IPO Year
2006
2008

Fundamental Metrics

Financial Performance
Metric
PRTS
CTSO
Price
$0.82
$0.80
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$0.50
$5.38
AVG Volume (30 Days)
987.0K
67.9K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$7.29
Revenue Next Year
N/A
$8.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$0.37
$0.60
52 Week High
$1.36
$1.39

Technical Indicators

Market Signals
Indicator
PRTS
CTSO
Relative Strength Index (RSI) 69.09 61.97
Support Level $0.70 $0.61
Resistance Level $0.93 $0.84
Average True Range (ATR) 0.06 0.04
MACD 0.01 0.01
Stochastic Oscillator 70.70 75.78

Price Performance

Historical Comparison
PRTS
CTSO

About PRTS CarParts.com Inc.

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: